Physiomics Plc (AIM:PYC)
London · Delayed Price · Currency is GBP · Price in GBX 0.4500
-0.0250 (-5.26%)
Oct 16, 2026, 4:13 PM GMT
Physiomics Income Statement
Financials in millions GBP. Fiscal year is July - June.
Millions GBP. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Revenue | 0.94 | 0.78 | 0.54 | 0.6 | 0.83 |
Other Revenue | 0.11 | 0.05 | 0.03 | 0.01 | 0.07 |
| 1.06 | 0.83 | 0.57 | 0.61 | 0.9 | |
Revenue Growth | 26.50% | 46.20% | -5.81% | -32.75% | 23.23% |
Cost of Revenue | 1.71 | 1.27 | 1.22 | 1.16 | 1.24 |
Gross Profit | -0.65 | -0.44 | -0.65 | -0.55 | -0.34 |
Selling, General & Admin | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 |
Amortization of Goodwill & Intangibles | 0 | 0 | 0 | 0 | 0 |
Operating Expenses | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 |
Operating Income | -0.69 | -0.46 | -0.67 | -0.57 | -0.36 |
Interest Expense | -0 | - | -0 | - | - |
Interest & Investment Income | 0 | 0 | 0 | 0 | 0 |
Currency Exchange Gain (Loss) | -0 | -0 | -0 | -0 | -0 |
EBT Excluding Unusual Items | -0.69 | -0.46 | -0.67 | -0.57 | -0.36 |
Gain (Loss) on Sale of Assets | 0 | - | -0 | 0 | - |
Pretax Income | -0.69 | -0.46 | -0.67 | -0.57 | -0.36 |
Income Tax Expense | 0.01 | -0.04 | -0.06 | -0.09 | -0.11 |
Net Income | -0.7 | -0.42 | -0.61 | -0.48 | -0.25 |
Net Income to Common | -0.7 | -0.42 | -0.61 | -0.48 | -0.25 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 346 | 238 | 135 | 97 | 97 |
Shares Outstanding (Diluted) | 346 | 238 | 135 | 97 | 97 |
Shares Change | 45.08% | 75.94% | 38.95% | 0.05% | 0.25% |
EPS (Basic) | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
EPS (Diluted) | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -0.57 | -0.55 | -0.57 | -0.27 | -0.36 |
Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
Gross Margin | -61.75% | -52.16% | -113.94% | -91.11% | -37.41% |
Operating Margin | -64.96% | -54.59% | -117.48% | -94.65% | -39.81% |
Profit Margin | -66.06% | -49.78% | -106.80% | -78.79% | -28.10% |
Free Cash Flow Margin | -53.76% | -65.94% | -99.10% | -44.55% | -39.83% |
EBITDA | -0.68 | -0.45 | -0.66 | -0.56 | -0.35 |
EBITDA Margin | -64.12% | -53.51% | -115.91% | -92.93% | -38.57% |
D&A For EBITDA | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
EBIT | -0.69 | -0.46 | -0.67 | -0.57 | -0.36 |
EBIT Margin | -64.96% | -54.59% | -117.48% | -94.65% | -39.81% |
Revenue as Reported | 1.06 | 0.83 | 0.57 | 0.61 | 0.9 |